Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation

Area of Science:

• Microbiome research
• Cancer treatment
• Immunology

Background:

• The human microbiome plays a crucial role in health and disease.
• Allogeneic hematopoietic cell transplantation (HCT) is a vital cancer treatment.
• The interaction between the microbiome and HCT is a growing area of research.

Purpose of the Study:

• To review recent discoveries on the microbiome's role in HCT.
• To describe strategies for microbiome manipulation in HCT patients.
• To highlight the potential for improving HCT outcomes through microbiome-targeted interventions.

Main Methods:

• Literature review of microbiome and HCT interactions.
• Analysis of ongoing and proposed clinical trials.
• Synthesis of current knowledge on microbiome-modulating strategies.

Main Results:

• The microbiome influences HCT prognosis, treatment response, and complications.
• Several microbiome-targeted interventions are under investigation.
• Early findings suggest potential for improving HCT outcomes.

Conclusions:

• Targeting the microbiome offers a promising approach to enhance allogeneic HCT efficacy.
• Further research and clinical trials are needed to optimize microbiome-based therapies.
• Personalized microbiome modulation could revolutionize cancer care.